End of April 2021, the European Commission published a report on “new genomic techniques” which was awaited by developers of these biotechnologies, since it was expected to have major implications for their regulation in the European Union (EU). Furthermore, European regulation would affect the global marketing of these products depending on the closing or opening … Continue reading “New genomic techniques”: where is Europe going?